Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733069 | SCV000861088 | pathogenic | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003621568 | SCV004397446 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-05-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr106Serfs*8) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. For these reasons, this variant has been classified as Pathogenic. |